A Real-world Study of Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma
Clinical trial NCT05852028 · UNKNOWN
Trial details
- NCT number
- NCT05852028
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-15
- Primary completion
- 2024-10-10
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.